The post-COVID condition (PCC) is a pathology stemming from COVID-19, and studying its
pathophysiology, diagnosis, and treatment is crucial. Neuroinflammation causes the most …

Consequences of the disease produced by the severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) have led to an urgent search for preventive and therapeutic …

Purpose Post-infectious olfactory dysfunction (PIOD) is one of the most common causes of
olfactory impairment but has limited treatment options. Recently, olfactory training (OT) has …

Purpose of Review COVID-19 associated olfactory dysfunction is widespread, yet effective
treatment strategies remain unclear. This article aims to provide a comprehensive systematic …

Interest in preventative dietary interventions for human health has increasingly focused on
the endocannabinoid (eCB)-like compound palmitoylethanolamide (PEA), a bioactive lipid …

Background As the novel coronavirus disease 2019 (COVID-19) pandemic subsides, the
clinical sequelae are becoming more problematic. Interestingly, the statistical data indicate …

The acute manifestations of coronavirus disease 2019 (COVID-19) exhibit the hallmarks of
sepsis-associated complications that reflect multiple organ failure. The inflammatory …

As the SARS-CoV-2 pandemic progressed, some survivors noted prolonged symptoms
following acute infection, termed post-acute sequelae of COVID-19 (PASC) or “long COVID.” …

Some individuals with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
experience anosmia, or loss of smell. Although the prevalence of anosmia has decreased …

Objectives Upper respiratory tract infections, including COVID-19, are associated with
olfactory dysfunction and there is a need for novel therapeutic approaches. The aim of study …